Identification of two novel susceptibility genes to Takayasu Arteritis

(left)Fig. 1. Results of genome-scanning. X:Chromosomal position Y: Strength of association.(right)Fig. 2. Synergistic effect between IL12B and HLA-B*52:01.

Two novel susceptibility genes to Takayasu Arteritis have been identified by a research group from the Department of Rhematology and Clinical Immunology, Kyoto University Graduate School of Medicine. This study was published in American Journal of Human Genetics on July 4th, 2013.

Takayasu Arteritis (TAK) was reported for the first time by Japanese ophthalmologist, Prof. Migito Takayasu in 1908. TAK affects especially young women aged between 15 and 35. TAK is characterized by the involvement of large arteries especially the aorta and its large branches. Individuals with TAK develop a wide range of symptoms such as fatigue and lowering of vision in addition to its characteristic complications including aortic regurgitation (AR), pulseless and difference of blood pressure between right and left upper limbs (so it is also called 'pulseless disease'). Although corticosteroid and are often used for treatment of TAK, TAK often flares up during treatment.

Previous studies have revealed that are involved in the pathogenesis of TAK, and HLA-B*52:01 is so far the only established across the world.

The research group performed a genome-wide association (GWA) study of 167 TAK cases and 663 healthy controls and identified six candidates of susceptibility loci (Figure 1). We also performed a replication study consisting of 212 TAK cases and 1,322 controls. As a result, we found that the IL12B region (overallp=1.7x10-13) and the MLX region (overallp=5.2x10-7) as well as the HLA-B region (overallp=2.8x10-21) as susceptibility loci to TAK. IL12B encodes IL12p40 protein, a subunit of well-known inflammatory cytokine. MLX encodes a transcription factor whose significance is unknown. We also found a between the IL12B polymorphism and HLA-B*52:01. Those who were positive for both IL12B polymorphism and HLA-B*52:01 had odds ratio of 6.00 (95? confidence interval (CI):4.22-8.55), while those who were positive only for HLA-B*52:01 or the IL12B polymorphism showed OR of 1.80 (95?CI:1.11-2.93) or 1.74 (95?CI:1.23-2.47), respectively (Figure 2). In addition, we found that the IL12B polymorphism showed a significant association with clinical manifestations of TAK, including increased risk and severity of AR, a representative severe complication of TAK.

This is the first GWA study for TAK in the world. Low prevalence of this disease had made it difficult to collect DNA samples to obtain sufficient power to detect and perform a GWA study.

The associations between the IL12B polymorphism and clinical manifestations of TAK suggest the fundamental effects of IL12p40 protein on TAK progression as well as TAK onset. Previous studies have revealed that the IL12B region was associated with a wide variety of autoimmune disorders and infectious diseases, including psoriasis, inflammatory bowel diseases, and leprosy. Their findings indicate that common autoimmune mechanisms underlie the pathology of TAK and other autoimmune disorders such as psoriasis and inflammatory bowel diseases in which IL12B is involved as a genetic predisposing factor. Detection of these susceptibility loci will provide new insights to the basic mechanisms of TAK pathogenesis.

The research group is planning to analyze how IL12p40 exerts its effect on TAK pathology, using patients' samples. Further genetic analyses are under way to detect further susceptibility genes to TAK.

More information: Terao, C. et al. Two susceptibility loci to Takayasu arteritis reveal a synergistic role of the IL12B and HLA-B regions in a Japanese population, Am J Hum Genet, 2013.

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Scientists discover an on/off switch for aging cells

23 hours ago

(Medical Xpress)—Scientists at the Salk Institute have discovered an on-and-off "switch" in cells that may hold the key to healthy aging. This switch points to a way to encourage healthy cells to keep dividing ...

Gene variant that dramatically reduces 'bad' lipids

Sep 16, 2014

In the first study to emerge from the UK10K Project's cohort of samples from the general public, scientists have identified a rare genetic variant that dramatically reduces levels of certain types of lipids in the blood. ...

New diagnostic method identifies genetic diseases

Sep 16, 2014

People with genetic diseases often have to embark on an odyssey from one doctor to the next. Fewer than half of all patients who are suspected of having a genetic disease actually receive a satisfactory diagnosis. Scientists ...

User comments